PROMETH VC W/ CODEINE Drug Patent Profile
✉ Email this page to a colleague
When do Prometh Vc W/ Codeine patents expire, and when can generic versions of Prometh Vc W/ Codeine launch?
Prometh Vc W/ Codeine is a drug marketed by Nostrum Labs Inc and is included in one NDA.
The generic ingredient in PROMETH VC W/ CODEINE is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROMETH VC W/ CODEINE?
- What are the global sales for PROMETH VC W/ CODEINE?
- What is Average Wholesale Price for PROMETH VC W/ CODEINE?
Summary for PROMETH VC W/ CODEINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Patent Applications: | 1 |
| DailyMed Link: | PROMETH VC W/ CODEINE at DailyMed |
US Patents and Regulatory Information for PROMETH VC W/ CODEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Labs Inc | PROMETH VC W/ CODEINE | codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride | SYRUP;ORAL | 088764-001 | Oct 31, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
